Literature DB >> 19673187

Dosimetric effects of rotational output variation and x-ray target degradation on helical tomotherapy plans.

Robert J Staton1, Katja M Langen, Patrick A Kupelian, Sanford L Meeks.   

Abstract

In this study, two potential sources of IMRT delivery error have been identified for helical tomotherapy delivery using the HiART system (TomoTherapy, Inc., Madison, WI): Rotational output variation and target degradation. The HiArt system is known to have output variation, typically about +/- 2%, due to the absence of a dose servo system. On the HiArt system, x-ray target replacement is required approximately every 10-12 months due to target degradation. Near the end of target life, the target thins and causes a decrease in the beam energy and a softening of the beam profile at the lateral edges of the beam. The purpose of this study is to evaluate the dosimetric effects of rotational output variation and target degradation by modeling their effects and incorporating them into recalculated treatment plans for three clinical scenarios: Head and neck, partial breast, and prostate. Models were created to emulate both potential sources of error. For output variation, a model was created using a sine function to match the amplitude (+/- 2%), frequency, and phase of the measured rotational output variation data. A second model with a hypothetical variation of +/- 7% was also created to represent the largest variation that could exist without violating the allowable dose window in the delivery system. A measured beam profile near the end of target life was used to create a modified beam profile model for the target degradation. These models were then incorporated into the treatment plan by modifying the leaf opening times in the delivery sinogram. A new beam model was also created to mimic the change in beam energy seen near the end of target life. The plans were then calculated using a research version of the PLANNED ADAPTIVE treatment planning software from TomoTherapy, Inc. Three plans were evaluated in this study: Head and neck, partial breast, and prostate. The D50 of organs at risk, the D95 for planning target volumes (PTVs), and the local dose difference were used to evaluate the changes in the modified treatment plans. Dosimetric effects from rotational variation were found to be low (less than 1%) for a typical variation of +/- 2%. Even using a variation of +/- 7%, DVH values and dose distributions were altered by less than 2% for all scenarios. The dosimetric effects of target degradation were found to be slightly more significant. For a model using data taken just before target failure, dosimetric differences of 2%-4% were observed in the recalculated plans when compared to the original plans. The largest effects (up to 4.5%) were observed for PTVs that were located at deeper depths as seen in the prostate plan. Overall, the recalculated plans show that the dosimetric effects of rotational variation and target degradation are on the order of 1%-4% for helical tomotherapy on the HiART system and do not pose a risk for significant deviations from the original treatment plan.

Mesh:

Substances:

Year:  2009        PMID: 19673187     DOI: 10.1118/1.3134262

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  8 in total

1.  The effect and stability of MVCT images on adaptive TomoTherapy.

Authors:  Poonam Yadav; Ranjini Tolakanahalli; Yi Rong; Bhudatt R Paliwal
Journal:  J Appl Clin Med Phys       Date:  2010-07-02       Impact factor: 2.102

2.  Measurements to predict the time of target replacement of a helical tomotherapy.

Authors:  Severin Kampfer; Stefan Schell; Marciana N Duma; Jan J Wilkens; Peter Kneschaurek
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

3.  Improving dose calculations on tomotherapy MVCT images.

Authors:  Frederik Crop; Antoine Bernard; Nick Reynaert
Journal:  J Appl Clin Med Phys       Date:  2012-09-06       Impact factor: 2.102

4.  Long-term dosimetric stability of multiple TomoTherapy delivery systems.

Authors:  Jennifer B Smilowitz; David Dunkerley; Patrick M Hill; Poonam Yadav; Mark W Geurts
Journal:  J Appl Clin Med Phys       Date:  2017-05-02       Impact factor: 2.102

5.  A quality assurance tool for helical tomotherapy using a step-wedge phantom and the on-board MVCT detector.

Authors:  Vincent Althof; Paul van Haaren; Rik Westendorp; Tonnis Nuver; Dinant Kramer; Marijke Ikink; Arjen Bel; Andre Minken
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

6.  Technical note: Correlation between TQA data trends and TomoHD functional status.

Authors:  Hervé H F Choi; Joan P Y Ho; Bin Yang; Kin Yin Cheung; Siu Ki Yu
Journal:  J Appl Clin Med Phys       Date:  2014-03-06       Impact factor: 2.102

7.  Impact of very long time output variation in the treatment of total marrow irradiation with helical tomotherapy.

Authors:  Yutaka Takahashi; Susanta K Hui
Journal:  Radiat Oncol       Date:  2013-05-20       Impact factor: 3.481

8.  Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy.

Authors:  Yutaka Takahashi; Susanta K Hui
Journal:  Radiat Oncol       Date:  2014-01-25       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.